InNexus Biotechnology, Inc.
IXSBF
$0.00
$0.000.00%
OTC PK
03/31/2011 | 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 32.40K | 99.60K | 16.10K | 400.00 | 5.20K |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 2.70K | -- | 4.20K | 8.00K | 14.50K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 35.10K | 99.60K | 20.30K | 8.40K | 19.70K |
|
|||||
Total Current Assets | 35.10K | 99.60K | 20.30K | 8.40K | 19.70K |
Net Property, Plant & Equipment | 568.10K | 669.10K | 732.20K | 803.20K | 1.44M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 10.10K | 10.30K | 10.20K | 10.30K | 2.53M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 2.64M | 2.58M | 2.48M | 2.42M | -- |
Total Assets | 3.25M | 3.36M | 3.25M | 3.24M | 3.99M |
|
|||||
Total Accounts Payable | 1.98M | 1.91M | 1.81M | 2.00M | 2.07M |
Total Accrued Expenses | 721.60K | 560.10K | 443.70K | 569.00K | 467.80K |
Short-term Debt | -- | 2.20M | 2.21M | 2.14M | 2.25M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 6.64M | 4.08M | 3.60M | 3.17M | 3.02M |
Total Finance Division Other Current Liabilities | 243.30K | 227.70K | 209.60K | 194.50K | 193.00K |
Total Other Current Liabilities | 243.30K | 227.70K | 209.60K | 194.50K | 193.00K |
Total Current Liabilities | 9.59M | 8.98M | 8.28M | 8.07M | 8.00M |
|
|||||
Total Current Liabilities | 9.59M | 8.98M | 8.28M | 8.07M | 8.00M |
Long-Term Debt | 270.70K | 339.80K | 361.50K | -- | -- |
Short-term Debt | -- | 2.20M | 2.21M | 2.14M | 2.25M |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 0.00 | -- | -- | -- | -- |
Total Liabilities | 9.86M | 9.32M | 8.64M | 8.07M | 8.00M |
|
|||||
Common Stock & APIC | 21.87M | 26.69M | 25.37M | 24.26M | 24.60M |
Retained Earnings | -36.53M | -35.12M | -33.05M | -31.25M | -30.70M |
Treasury Stock & Other | 8.04M | 2.46M | 2.29M | 2.15M | 2.09M |
Total Common Equity | -6.62M | -5.97M | -5.40M | -4.84M | -4.02M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
|||||
Total Common Equity | -6.62M | -5.97M | -5.40M | -4.84M | -4.02M |
Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Minority Interest | 8.10K | 7.90K | 7.60K | 7.40K | 7.80K |
Total Equity | -6.61M | -5.97M | -5.39M | -4.83M | -4.01M |
|